On this basis, we combined the expression rates of common GBM targets from the literature with the expression levels of relevant genes in the TCGA database to select B7‐H3, IL‐13Rα2, Her2, and GD2 as the target pool for our multiple CAR‐γδ T cell cocktail therapy at present. Here, ERBB2 is linked to glioblastoma.